[A study of the serological response of Sudanese children to three associated immunizations (measles, tetanus, meningococcal A meningitis) (author's transl)]
- PMID: 110997
[A study of the serological response of Sudanese children to three associated immunizations (measles, tetanus, meningococcal A meningitis) (author's transl)]
Abstract
The authors first emphasize the efficiency and economic value of associated immunizations in developping countries. They report the first data collected in a campaign of immunization with a single injection of an extemporaneous mixture of antimeasles, antitetanus and antimeningococcal meningitis vaccines. This campaign took place in the Republic of Suddan from may 1976 to july 1977 and concerned 87 children. The specifications of each vaccine as well as the procedures of vaccination and serological control are given. The study of serological rates shows: -- a good response for measles with, in Africa, an optimal âge of 6 months and a new injection 6 months later; -- a low and late antibodies rise in tetanus with a good immunological memory giving way to an acute rise under a 2nd injection one year later; -- an immediate increase of the basic low rate of meningococcic antibodies existing in most Suddanese children before the injection. The authors consider the advantage of using also anti C meningococcal vaccine and to add an inactivated poliomyelitic vaccine. They give notice of the good stability in tropical environment of the vaccinal mixture they used.
Similar articles
-
Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine.Dev Biol Stand. 1978;41:209-16. Dev Biol Stand. 1978. PMID: 111980
-
Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.Pediatrics. 1990 Apr;85(4 Pt 2):682-9. Pediatrics. 1990. PMID: 2107519 Clinical Trial.
-
A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.Bull World Health Organ. 1973;49(3):301-5. Bull World Health Organ. 1973. PMID: 4211056 Free PMC article.
-
Long-term protection in children with meningococcal C conjugate vaccination: lessons learned.Expert Rev Vaccines. 2006 Dec;5(6):851-7. doi: 10.1586/14760584.5.6.851. Expert Rev Vaccines. 2006. PMID: 17184222 Review.
-
Two-dose measles vaccination schedules.Bull World Health Organ. 1993;71(3-4):421-8. Bull World Health Organ. 1993. PMID: 8324862 Free PMC article. Review.
Cited by
-
The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy.BMJ Open. 2012 Jul 19;2(4):e000761. doi: 10.1136/bmjopen-2011-000761. Print 2012. BMJ Open. 2012. PMID: 22815465 Free PMC article.